print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST
05/11/2014 (Added to site)
Author(s): Nikolova, B.; Peycheva, E.; Mudrov, T.; Dobreva, T.; Matveev, M.; Tsoneva, I.

Current Statement of Electrochemotherapy in Bulgaria

Journal: International Journal of Bioautomation, 18/1 (2014), pp. 31-44
DOI: n/a
Tell your friend  | 

Abstract: Electrochemotherapy is one fast, easy, effective and safe method for treatment of patients with clinical and cytological diagnosis of skin tumors as Carcinoma basocellulare, Carcinoma spinocellulare, Kaposi sarkoma and Mycosis fungoides in stage I (T1N0M0). Therapy is based on the temporary formation of pores on the surface of the cell membrane, resulting from the application of electric field with appropriate intensity and duration trough which the cytostatic drug as bleomycin is introduced into the tumor cells. This work presents data on the last version of electroporator and the treated patients by the method electrochemotherapy recently.



Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: